Program
Course overview
This training course aims at promoting an integrated technology in carbon-ion radiotherapy, providing basic knowledge and practice-oriented trainings concerning carbon-ion radiotherapy as well as other topics related to this field.
Target Group
This training course is targeted primarily at participants with some expertise in radiotherapy and those who are interested in carbon-ion radiotherapy. Not only that, but also, trainees in radiotherapy, radiation oncologists, medical physicists, radiation biologists, radiological technologists, and any individuals having interests in this field.
Program
Introduction
- History of CIRT
- Hirohiko Tsujii
- QST *
- J-CROS activities
- Hiroshi Tsuji
- QST *
- Cost effectiveness of CIRT
- Tatsuya Ohno
- Gunma University
Biology
- Characteristics of Carbon ion Radiotherapy in cancer therapy
- Marco Durante
- GSI Helmholtzzentrum für Schwerionenforschung
- Role of heavy-ion-induced free radicals
- Ryoichi Hirayama
- QST *
- Harnessing heavy ions to improve immunotherapy
- Takashi Shimokawa
- QST *
- Rationale for hypofractionation
- Yukari Yoshida
- Gunma University
- DNA damage and cell killing effects by high-LET particle beams
- Atsushi Shibata
- Gunma University
- Immune Radiotherapy
- Noriyuki Okonogi
- QST *
- Targeted Radionuclide Therapy
- Sumitaka Hasegawa
- QST *
- FLASH Particle Therapy
- Taku Inaniwa
- QST *
Physics
- Accelerators for CiRT inc. Quantum Scalpel
- Toshiyuki Shirai
- QST *
- Beam delivery, QA and Radiation protection
- Shunsuke Yonai
- QST *
- Biological models for CIRT
- Naruhiro Matsufuji
- QST *
- Treatment planning and Range uncertainty in CIRT
- Nobuyuki Kanematsu
- QST *
- Motion management
- Hideyuki Mizuno
- QST *
- IGRT with in-room CT
- Makoto Sakai
- Gunma University
- Facility design of Yonsei Cancer Center Korea
- Jin Sung Kim
- Yonsei Cancer Center
- Facility commissioning at Osaka
- Masaaki Takashina
- OSAKA HIMAK
- Facility commissioning at Yamagata
- Hikaru Souda
- Yamagata University
- What Particle Therapy Can Learn from IMRT and Other High- Precision Radiotherapies
- Arnold Pompos
- UTSouthwestern Medical Center
Clinical aspects
- Head & Neck
(including Skull base ＆Lacrimal gland) - Masashi Koto
- QST *
- Eye
- Masaru Wakatsuki
- QST *
- Lung
- Mio Nakajima
- QST *
- Liver
- Kei Shibuya
- Gunma University
- Pancreas
- Makoto Shinoto
- QST *
- Bone & Soft tissue Sarcoma
- Reiko Imai
- QST *
- Genitourinary tumors (prostate, kidney)
- Hitoshi Ishikawa
- QST *
- Locally recurrent Rectal cancer
- Hirotoshi Takiyama
- QST *
- Gynecological
- Kazutoshi Murata
- QST *
- Breast
- Yasumasa Mori
- QST *
Diagnosis
- Molecular diagnosis for radiotherapy
- Ryuichi Nishii
- QST *
- Diagnostic imaging for radiotherapy
- Riwa Kishimoto
- QST *
Topics
- Overview of Proton Therapy
- Hideyuki Sakurai
- Tsukuba University
- Rationale and Indications for CIRT at Mayo Clinic USA
- Robert L. Foote
- Mayo Clinic
- Overview of BNCT
- Yoshihiro Takai
- Southern Tohoku BNCT Research Center
- Radiation Emergency Medicine
- Hideo Tatsuzaki
- QST *
Vendor presentation
- Toshiba Corporation
- Hitachi, Ltd.
- Sumitomo Heavy Industries
- RaySearch Laboratories
- B dot Medical Inc.
Introduction of facilities
- QST *
- Gunma University Heavy Ion Medical Center
- Kanagawa cancer center
- Osaka Heavy Ion Therapy Center
- Hyogo Ion Beam Medical Center
- Saga Heavy ion Medical Accelerator in Tosu, SagaHIMAT
- Yamagata University East Japan Heavy Ion Center
*) QST : National Institutes for Quantum and Radiological Science and Technology